Schedule 13G ownership disclosure
Xenon Pharmaceuticals Inc
Security class unavailable · CUSIP: 98420N105
Event date: 2018-03-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-18-001102
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Mar 29, 2018
- Reporting period
- Mar 27, 2018
- Description
- Schedule 13G beneficial ownership